Skip to main content

Table 5 We presented a case study for breast cancer in the third way of case study, in which we only used known disease–miRNA association based on HMDDv1.0 database as test samples to assess the robustness of the prediction model, and then we verified the prediction results according to the experimental confirmed disease–miRNA associations recorded in HMDD v2.0 database, miR2Disease, and dbDEMC database

From: MKRMDA: multiple kernel learning-based Kronecker regularized least squares for MiRNA–disease association prediction

miRNA

Evidence

miRNA

Evidence

hsa-let-7b

dbdemc; HMDDv2

hsa-mir-130b

dbdemc

hsa-let-7e

dbdemc; HMDDv2

hsa-mir-363

dbdemc

hsa-mir-223

dbdemc; HMDDv2

hsa-mir-27a

dbdemc; miR2Disease; HMDDv2

hsa-mir-191

dbdemc; miR2Disease; HMDDv2

hsa-mir-198

dbDEMC

hsa-let-7i

dbdemc; miR2Disease; HMDDv2

hsa-mir-520c

miR2Disease; HMDDv2

hsa-mir-101

dbdemc; miR2Disease; HMDDv2

hsa-mir-521

dbdemc

hsa-mir-92a

HMDDv2

hsa-mir-520b

dbdemc; HMDDv2

hsa-let-7g

dbdemc; HMDDv2

hsa-mir-95

dbdemc

hsa-let-7c

dbdemc; HMDDv2

hsa-mir-128b

miR2Disease

hsa-mir-92b

dbdemc

hsa-mir-142

Unconfirmed

hsa-mir-16

dbdemc; HMDDv2

hsa-mir-15b

dbdemc

hsa-mir-106a

dbdemc

hsa-mir-100

dbdemc; HMDDv2

hsa-mir-32

dbdemc

hsa-mir-30e

Unconfirmed

hsa-mir-203

dbdemc; miR2Disease; HMDDv2

hsa-mir-491

dbdemc

hsa-mir-126

dbdemc; miR2Disease; HMDDv2

hsa-mir-182

dbdemc; miR2Disease; HMDDv2

hsa-mir-373

dbdemc; miR2Disease; HMDDv2

hsa-mir-130a

dbDEMC

hsa-mir-99a

dbDEMC

hsa-mir-199b

dbdemc; miR2Disease; HMDDv2

hsa-mir-532

dbDEMC

hsa-mir-184

dbdemc

hsa-mir-18b

dbdemc; HMDDv2

hsa-mir-455

dbdemc

hsa-mir-335

dbdemc; miR2Disease; HMDDv2

hsa-mir-139

dbdemc; HMDDv2

hsa-mir-24

dbdemc; HMDDv2

hsa-mir-107

dbdemc; HMDDv2

hsa-mir-181a

dbdemc; miR2Disease; HMDDv2

hsa-mir-186

dbdemc

hsa-mir-124

dbdemc; HMDDv2

hsa-mir-99b

dbdemc

hsa-mir-30a

miR2Disease; HMDDv2

hsa-mir-29c

dbdemc; miR2Disease; HMDDv2

hsa-mir-196b

dbdemc

hsa-mir-542

Unconfirmed

  1. As a result, among the top 10 and 50 potential breast cancer related miRNAs, 10 and 47 were confirmed